ORBIMED ADVISORS LLC Q1 2019 Filing
Filed May 15, 2019
Portfolio Value
$6.5B
Holdings
119
Report Date
Q1 2019
Filing Type
13F-HR
All Holdings (119 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | ASNSUSDX4 PHARMACEUTICALS INC | 311,493 | $5.4B | 83.95% | |
| 102 | ATNXEURATHENEX INC | 430,000 | $5.3B | 81.55% | |
| 103 | NVTA1EURINVITAE CORP | 222,017 | $5.2B | 80.50% | |
| 104 | —MENLO THERAPEUTICS INC | 633,920 | $5.0B | 77.03% | |
| 105 | CTIC1USDCTI BIOPHARMA CORP | 5,000,000 | $4.9B | 75.10% | |
| 106 | —AERPIO PHARMACEUTICALS INC | 5,193,946 | $4.7B | 72.45% | |
| 107 | —AVROBIO INC | 198,583 | $4.4B | 67.79% | |
| 108 | —REALM THERAPEUTICS PLC | 1,021,484 | $3.9B | 60.89% | |
| 109 | —NUVECTRA CORP | 350,000 | $3.9B | 59.66% | |
| 110 | AERIEURAERIE PHARMACEUTICALS INC | 58,000 | $2.8B | 42.65% | |
| 111 | KALVKALVISTA PHARMACEUTICALS INC | 90,500 | $2.6B | 40.09% | |
| 112 | KRYSKRYSTAL BIOTECH INC | 59,210 | $1.9B | 30.16% | |
| 113 | —MARINUS PHARMACEUTICALS INC | 398,101 | $1.7B | 25.76% | |
| 114 | —AEGERION PHARMACEUTICALS INC | 2,000,000 | $1.4B | 21.38% | |
| 115 | SNDXSYNDAX PHARMACEUTICALS INC | 212,000 | $1.1B | 17.23% | |
| 116 | —SIERRA ONCOLOGY INC | 317,104 | $542.0M | 8.39% | |
| 117 | —BIOLINERX LTD | 1,038,600 | $447.0M | 6.92% | |
| 118 | SCTLRECRO PHARMA INC | 43,499 | $255.0M | 3.95% | |
| 119 | —MEDIGUS LTD | 15,000 | $44.0M | 0.68% |
PreviousPage 2 of 2